
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+20
Curiox Biosystems is committed to enabling accurate biological analysis through automation. Next-generation methods and applications--including single-cell omics technologies, flow cytometry, immunotherapy, and cell and gene therapy--deserve a next-generation approach to preparing samples for analysis. Thats why Curiox invented Laminar Wash technology, the only sample preparation method that eliminates centrifugation and the problems it introduces. The methodology keeps cells in their native state, improves cell retention and viability, and enhances reproducibility and miniaturization, ultimately leading to reduced costs and workflow standardization
Cell-based assays,wash-based suspension cell assays,primary cell screens,assay miniaturization,centrifuge,immunology,covid,biosafety,sample preparation,automation,antibody discovery,cell therapy,immunoassays,flow cytometry,mass cytometry,single cell,proteogenomics,seq,cytof,fluidigm,10x genomics,phenotyping,oncology,clinical,and research and development
Curiox biosystems operates in the Biotechnology research industry.
Curiox biosystems's revenue is 11m - 100m
Curiox biosystems has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.